Mechanisms of eukaryotic transcription activation

真核转录激活机制

基本信息

  • 批准号:
    7880515
  • 负责人:
  • 金额:
    $ 52.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-01 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Summary Activation of transcription is the ultimate endpoint for many signal transduction and developmental pathways, and understanding the mechanism of activation is a key to understanding gene regulation. From previous studies, it is clear that disruption of normal gene regulation by mutations in gene- specific transcription activators and coactivators can lead to cancer and other diseases. The broad long- term objectives of this proposal are to determine the mechanisms used by gene-specific activators and coactivators to regulate RNA polymerase II transcription. The proposed work will provide a basis for understanding gene regulation in normal and diseased states at the molecular level. The specific aims of this work utilize biochemical, structural, and molecular genetic methods to examine the direct targets of two activation domains and two coactivators. We will examine the structure of several acidic activator-coactivator complexes to understand how activators specifically recognize their targets, common principals of activator-target recognition and, more generally, the function of intrinsically disordered proteins. We will examine the interaction of the SAGA coactivator with TBP (TATA binding protein) and how this interaction is regulated by acetylation. Using a unique set of crosslinking reagents, we will examine the direct targets of the Mediator coactivator complex within the transcription machinery. In all cases, we will use yeast molecular genetics to test the functional significance of our biochemical results. Combined, our results will lead to a molecular model for how activators recognize their coactivator targets and how coactivators stimulate gene expression by direct interaction with the transcription machinery. PUBLIC HEALTH RELEVANCE: Project Narrative The objective of this research is to understand the mechanism and regulation of transcription, the process of mRNA synthesis. Regulation of transcription is one of the key steps in control of cell growth, differentiation, and development, and defects in transcription directly contribute to many human illnesses. Understanding the mechanism of transcription and its regulation will form the basis for understanding the molecular defects in transcription disorders leading to many types of cancer, as well as heart disease, neurological disorders, and birth defects.
描述(由申请人提供):转录的摘要激活是许多信号转导和发育途径的最终终点,理解激活的机理是理解基因调节的关键。从以前的研究中可以明显看出,基因转录激活剂和共激活剂中突变对正常基因调节的破坏会导致癌症和其他疾病。该提案的广泛长期目标是确定基因特异性激活剂和共激活剂用于调节RNA聚合酶II转录的机制。拟议的工作将为理解分子水平正常和患病状态的基因调节提供基础。这项工作的具体目的利用生化,结构和分子遗传学方法来检查两个激活域和两个共激活因子的直接靶标。我们将检查几种酸性激活剂互启动剂复合物的结构,以了解激活剂如何专门识别其靶标,激活剂 - 目标识别的常见原理以及更一般而言的本质上无序蛋白的功能。我们将检查传奇共激活因子与TBP(TATA结合蛋白)的相互作用,以及如何通过乙酰化调节这种相互作用。使用一组独特的交联试剂,我们将检查转录机械内介体共激活器复合物的直接靶标。在所有情况下,我们都将使用酵母分子遗传学来测试我们的生化结果的功能意义。结合在一起,我们的结果将导致一个分子模型,用于激活剂如何识别其共激活剂靶标,以及共激活因子如何通过与转录机械直接相互作用刺激基因表达。 公共卫生相关性:项目叙述这项研究的目的是了解转录的机制和调节,即mRNA合成过程。转录的调节是控制细胞生长,分化和发育的关键步骤之一,转录缺陷直接导致许多人类疾病。了解转录的机制及其调节将构成理解转录疾病中分子缺陷的基础,导致许多类型的癌症以及心脏病,神经系统疾病和先天缺陷。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Steven M Hahn的其他基金

Mechanisms of transcriptional regulation and transcription factor specificity
转录调控机制和转录因子特异性
  • 批准号:
    10164063
    10164063
  • 财政年份:
    2021
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of transcriptional regulation and transcription factor specificity
转录调控机制和转录因子特异性
  • 批准号:
    10662197
    10662197
  • 财政年份:
    2021
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of transcriptional regulation and transcription factor specificity
转录调控机制和转录因子特异性
  • 批准号:
    10397115
    10397115
  • 财政年份:
    2021
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Transcriptional Regulation During Cell Growth Differentiation and Development
细胞生长分化和发育过程中的转录调控
  • 批准号:
    7162507
    7162507
  • 财政年份:
    2006
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of eukaryotic transcription activation
真核转录激活机制
  • 批准号:
    7279212
    7279212
  • 财政年份:
    2005
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of eukaryotic transcription activation
真核转录激活机制
  • 批准号:
    8770495
    8770495
  • 财政年份:
    2005
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of eukaryotic transcription activation
真核转录激活机制
  • 批准号:
    6961840
    6961840
  • 财政年份:
    2005
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of eukaryotic transcription activation
真核转录激活机制
  • 批准号:
    7493054
    7493054
  • 财政年份:
    2005
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of eukaryotic transcription activation
真核转录激活机制
  • 批准号:
    7092225
    7092225
  • 财政年份:
    2005
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Mechanisms of eukaryotic transcription activation
真核转录激活机制
  • 批准号:
    8049212
    8049212
  • 财政年份:
    2005
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:

相似国自然基金

基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
  • 批准号:
    62302456
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
  • 批准号:
    62371403
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于深度学习预测小分子与人类突变激酶结合亲和力的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
反复非平衡结合联合迭代筛选发掘混合物中痕量高亲和力配体的方法及其应用
  • 批准号:
    82273900
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
全新从头快速设计靶向COVID-19病毒及其突变株S蛋白超高亲和力阻断结合蛋白研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目

相似海外基金

Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
  • 批准号:
    10727268
    10727268
  • 财政年份:
    2023
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Configuration-specific cofactors of Oct4
Oct4 的配置特定辅因子
  • 批准号:
    10713592
    10713592
  • 财政年份:
    2023
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Scalable platforms for understudied histone modifications and modifiers
用于未充分研究的组蛋白修饰和修饰剂的可扩展平台
  • 批准号:
    10567849
    10567849
  • 财政年份:
    2023
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别:
Restore the Tumor-Suppressive Activities of p53 Mutants
恢复 p53 突变体的肿瘤抑制活性
  • 批准号:
    10716397
    10716397
  • 财政年份:
    2023
  • 资助金额:
    $ 52.05万
    $ 52.05万
  • 项目类别: